Proton Rahman

1998–2025 年に発表

127
論文数
21,983
被引用数
77
h 指数
118
i10 指数

被引用数

Proton Rahman の年別被引用数1964 年: 被引用 1 件1972 年: 被引用 1 件1998 年: 被引用 4 件2000 年: 被引用 6 件2001 年: 被引用 10 件2002 年: 被引用 9 件2003 年: 被引用 16 件2004 年: 被引用 29 件2005 年: 被引用 51 件2006 年: 被引用 36 件2007 年: 被引用 45 件2008 年: 被引用 49 件2009 年: 被引用 116 件2010 年: 被引用 120 件2011 年: 被引用 192 件2012 年: 被引用 204 件2013 年: 被引用 249 件2014 年: 被引用 238 件2015 年: 被引用 319 件2016 年: 被引用 230 件2017 年: 被引用 296 件2018 年: 被引用 337 件2019 年: 被引用 886 件2020 年: 被引用 961 件2021 年: 被引用 980 件2022 年: 被引用 643 件2023 年: 被引用 493 件2024 年: 被引用 659 件2025 年: 被引用 299 件2026 年: 被引用 4 件1965〜1971 年は被引用が無いため表示していません1973〜1997 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,802 件、この内訳の 19.2%イギリス: 引用元論文 943 件、この内訳の 10.1%カナダ: 引用元論文 612 件、この内訳の 6.5%中国: 引用元論文 604 件、この内訳の 6.4%ドイツ: 引用元論文 602 件、この内訳の 6.4%イタリア: 引用元論文 458 件、この内訳の 4.9%オランダ: 引用元論文 358 件、この内訳の 3.8%フランス: 引用元論文 337 件、この内訳の 3.6%スペイン: 引用元論文 310 件、この内訳の 3.3%オーストラリア: 引用元論文 282 件、この内訳の 3%スイス: 引用元論文 269 件、この内訳の 2.9%日本: 引用元論文 239 件、この内訳の 2.6%
0%19.2%その他 27.3%

分野

  • Medicine51.8%
  • Immunology and Microbiology26.3%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Neuroscience0.7%
  • Mathematics0.5%
  • Computer Science0.4%
  • その他1.7%

トピック

  • Psoriasis: Treatment and Pathogenesis12.4%
  • Spondyloarthritis Studies and Treatments9.9%
  • Rheumatoid Arthritis Research and Therapies7.4%
  • Dermatology and Skin Diseases4.2%
  • Systemic Lupus Erythematosus Research3.9%
  • Autoimmune and Inflammatory Disorders Research3.5%
  • その他58.7%

共著者

全論文

検索で開く
  1. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial

    著者: , , , , , , , , , , , - The Lancet 2020 被引用: 344

  2. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Benedicte A Lie, Øystein Førre, Jaakko Tuomilehto, Kari Laiho, Lei Jiang, Yu Liu, Xin Wu, Huji Xu, Dirk Elewaut, Ruben Burgos-Vargas, Simon Stebbings, Nigil Haroon, Robert D Inman, Manuel A Ferreira, Juan Mulero, Jose Luis Fernandez-Sueiro, Miguel A Gonzalez-Gay, Carlos Lopez-Larrea, Panos Deloukas, Peter Donnelly, Karl Gafney, Hill Gaston, Dafna D Gladman, Proton Rahman, Walter P Maksymowych, J Bart A Crusius, Irene E van der Horst-Bruinsma, Chung-Tei Chou, Raphael Valle-Oñate, Consuelo Romero-Sánchez, Inger Myrnes Hansen, Fernando M Pimentel-Santos, Vibeke Videm, Javier Martin, David M Evans - Nature Genetics 2013 被引用: 873

  3. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2009 被引用: 1,396

  4. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xiaoquan Wen, Nicholas Eriksson, Hyun Min Kang, David A. Hinds, Rajan P. Nair, Gonçalo R. Abecasis, James T Elder - Nature Communications 2017 被引用: 400

  5. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cisca Wijmenga, Cordelia Langford, Sarah Edkins, Robert Andrews, Hannah Blackburn, Amy Strange, Gavin Band, Richard D. Pearson, Damjan Vukcevic, Chris C. A. Spencer, Panos Deloukas, Ulrich Mrowietz, Stefan Schreiber, Stephan Weidinger, Sulev Kõks, Külli Kingo, Tõnu Esko, Andres Metspalu, Henry W. Lim, John J. Voorhees, Michael Weichenthal, H.‐Erich Wichmann, Vinod Chandran, Cheryl F. Rosen, Proton Rahman, Dafna D. Gladman, C.E.M. Griffiths, André Reis, Juha Kere, Rajan P. Nair, André Franke, Jonathan N W N Barker, Gonçalo R. Abecasis, James T Elder, Richard C. Trembath - Nature Genetics 2012 被引用: 1,047

  6. Psoriatic arthritis from a mechanistic perspective

    著者: , , , , , - Nature Reviews Rheumatology 2022 被引用: 157

  7. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , - The Lancet 2015 被引用: 850

  8. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    著者: , , , , , , , , , , - The Lancet 2013 被引用: 798

  9. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

    著者: , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 740

  10. An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Massimo Gadina, Barbara Yang, Benjamin D. Korman, Peter K. Gregersen, P. Martin van Hagen, A. Elisabeth Hak, Marjan Huizing, Proton Rahman, Daniel C. Douek, Elaine F. Remmers, Daniel L. Kastner, Raphaela Goldbach‐Mansky - New England Journal of Medicine 2009 被引用: 992

  11. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. S. Hill Gaston, Malcolm Smith, Jácome Bruges‐Armas, Ana Rita Couto, Rosa Sorrentino, Fabiana Paladini, Manuel A. R. Ferreira, Huji Xu, Yu Liu, Lei Jiang, Carlos López‐Larrea, Roberto Díaz‐Peña, Antonio López‐Vázquez, Tetyana Zayats, Gavin Band, Céline Bellenguez, Hannah Blackburn, Jenefer M. Blackwell, Elvira Bramon, Suzannah J. Bumpstead, Juan Pablo Casas, Aiden Corvin, Nicholas Craddock, Panos Deloukas, Serge Dronov, Audrey Duncanson, Sarah Edkins, Colin Freeman, Matthew Gillman, Emma Gray, Rhian Gwilliam, Naomi Hammond, Sarah Hunt, Janusz Jankowski, Alagurevathi Jayakumar, Cordelia Langford, Jennifer Liddle, Hugh S. Markus, Christopher G. Mathew, Owen T McCann, Mark I. McCarthy, Colin N A Palmer, Leena Peltonen, Robert Plomin, Simon Potter, Anna Rautanen, Rathi Ravindrarajah, Michelle Ricketts, Nilesh J. Samani, Stephen Sawcer, Amy Strange, Richard C. Trembath, Ananth C. Viswanathan, Matthew Waller, Paul A. Weston, Pamela Whittaker, Sara Widaa, Nicholas Wood, Gil McVean, John D. Reveille, B P Wordsworth, Matthew A. Brown, Peter Donnelly - Nature Genetics 2011 被引用: 907

  12. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rajat K. Dhar, Eva Dokoupilová, Rita M. Egan, Andrea Everding, E. Galíndez, Mark C. Genovese, David H. Goddard, Alice B. Gottlieb, Philippe Goupille, Robert Griffin, Ramesh C. Gupta, Stephen Hall, Kalpita Hatti, Mary P. Howell, Yu‐Huei Huang, Ramina Jajoo, Namieta M. Janssen, Uta Kiltz, Alan Kivitz, Steven J. Klein, Mariusz Korkosz, Roshan Kotha, Joel M. Kremer, C Lue, José Luís Marenco de la Fuente, Helena Marzo‐Ortega, Jordi Gratacós Masmitja, Philip J. Mease, Pier Luigi Meroni, Eric C. Mueller, Anupama Nandagudi, Peter Nash, Antonio Fernández‐Nebro, C. Michael Neuwelt, Ana‐Maria Orbai, Meera R. Oza, Deborah L. Parks, Debendra Pattanaik, Maria Rell‐Bakalarska, David Rosmarin, Euthalia Roussou, Anna I. Rychlewska-Hanczewksa, David Sikes, Michael T. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen‐Fang Tsai, Anthony Turkiewicz, L. Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng-Chung Wei, Alvin F. Wells, Peter Youssef, Agnieszka Zielińska - The Lancet 2017 被引用: 405

  13. Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Henry W. Lim, Stephan Weidinger, Michael Weichenthal, John J. Voorhees, Proton Rahman, Peter K. Gregersen, André Franke, Dafna D. Gladman, Gonçalo R. Abecasis, James T. Elder - The American Journal of Human Genetics 2015 被引用: 322

  14. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frédéric Morin, Proton Rahman, Aaron Alejandro Barrera Rodriguez, Fidencio Cons-Molina, Sergio Duran Barragan, Cassandra M. Skinner, César Pacheco‐Tena, César Ramos-Remus, Juan Cruz Rizo Rodriguez, Seung-Jae Hong, Yeon-Ah Lee, Ji Hyeon Ju, Seong Wook Kang, Tae‐Hwan Kim, Chang Keun Lee, Eun Bong Lee, Sang Heon Lee, Min‐Chan Park, Kichul Shin, Sang‐Hoon Lee, Hung-An Chen, Ying‐Chou Chen, Song‐Chou Hsieh, Joung‐Liang Lan, Zdeněk Dvořák, Radka Moravcová, Martina Malcova, Yoshinori Taniguchi, Mitsumasa Kishimoto, Kurisu Tada, Hiroaki Dobashi, Kentaro Inui, Yukitaka Ueki, Yoshifuji Matsumoto, Yoshinobu Koyama, Kazuhiro Hatta, Tatsuya Atsumi, Midori Goto, Kiyoshi Matsui, Yuya Takakubo, Gunther Neeck, Denis Poddubnyy, Andrea Rubbert‐Roth, Malgorzata Szymańska, Tomasz Blicharski, Anna Dudek, Artur Racewicz, Rafał Wojciechowski, Marleen van de Sande, E. N. Griep, Mike Nurmohamed, Galina Matsievskaya, Е. Шмидт, Marina Stanislav, S. S. Yakushin, О. Б. Ершова, А. П. Ребров, Tibor Balázs, Regina Cseuz, Edit Drescher, Gyula Poór - The Lancet 2018 被引用: 359

  15. Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III, Randomized, Double‐Blind, Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis

    著者: , , , , , , , , , , , - Arthritis & Rheumatology 2021 被引用: 105

  16. Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

    著者: , , , , , , , , , - Annals of the Rheumatic Diseases 2021 被引用: 85

  17. Accrual of organ damage over time in patients with systemic lupus erythematosus.

    著者: , , , , - 2003 被引用: 336

  18. Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 被引用: 141

  19. Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis

    著者: , , , , , , , , , , , , , , , - Drug Safety 2023 被引用: 55

  20. Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

    著者: , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2018 被引用: 233

  21. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ana Claudia Melazzi, Luis Roimicher, Antônio Scafuto Scotton, Aaron Alejandro Barrera Rodriguez, Francisco Fidencio Cons Molina, Sergio Duran Barragan, Cassandra M. Skinner, César Pacheco‐Tena, Cesar Ricardo Ramos Remus, Juan Cruz Rizo Rodriguez, Seung‐Jae Hong, Seong Wook Kang, Chang Keun Lee, Eun Bong Lee, Sang Heon Lee, Min‐Chan Park, Sang‐Hoon Lee, Eva Dokoupilová, Zdeněk Dvořák, Martina Malcova, Karel Pvelka, Kari K. Eklund, Pentti A. Järvinen, Anna Karjalainen, Leena Paimela, Yoshinori Taniguchi, Tokutaro Tsuda, Kurisu Tada, Hiroaki Dobashi, Kentaro Inui, Yukitaka Ueki, Yoshifuji Matsumoto, Kazuhiro Hatta, Tatsuya Atsumi, Midori Goto, Shigeru Honjo, Kiyoshi Matsui, Yuya Takakubo, Gunther Neeck, Sylke Wagner, Jürgen Braun, Tomasz Blicharshi, Anna Dudek, Pawel Hrycai, Rafal Plebanski, Janina Drabiszcak-Piatkowska, Jan Brzezicki, Marek Krogulec, Daniela Opriș-Belinski, Ana Maria Ramazan, Luminita Tronaru, Marleen G. van de Sande, Galina Matsievskaya, E. A. Schmidt, Marina Stanislav, S. S. Yakushin, О. Б. Ершова, Andrey Rebroy, Melvin Churchill, Kathleen P. Flint, Maria Greenwald, Mary P. Howell, Jeffrey Kaine, Alan Kivitz, Steven J. Klein, Eric C. Mueller, Eric Peters, Roel Querubin, Michael E. Sayers, Craig D. Scoville ほか 17 名 - The Lancet 2019 被引用: 214

  22. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , SA Fretzin, E George, G Gladstein, RM Griffin, MW Grisanti, L Guenther, W Gulliver, K Hobbs, E Huang, E Ilivanova, S Jeka, M Khraishi, M Kokhan, N Korman, R Kunynetz, CL Leonardi, C Lessard, U Lindquist, A Martin, RT Matheson, FT Murphy, E Nasonov, W Palmer, K Papp, J Rech, M Rell-Bakalarska, P Rich, C Rosen, A Rudin, A Ruppert-Roth, C Scheinecker, S Seigel, S Shaikh, T Sheeran, WJ Shergy, EL Siegel, S Sierakowski, H Sofen, S Szanto, H Tahir, E Telegdy, D Toth, D Walker, AG Wilson, M Witt, J Wollenhaupt, D Zoschke, A Zubrzycka - Annals of the Rheumatic Diseases 2014 被引用: 658

  23. Endotypes of primary osteoarthritis identified by plasma metabolomics analysis

    著者: , , , , , , , - Lara D. Veeken 2020 被引用: 56

  24. Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - BMJ Open 2022 被引用: 53